BofA Securities raised the price target for the Cronos Group Inc. (NASDAQ:CRON) stock to “an Underperform”. The rating was released on April 28, 2021. We previously noted in another research note published on February 22, 2021 by CIBC that downgraded the stock from a Sector outperform to a Neutral with a price target of $12.50 for CRON stock.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Cronos Group Inc. (NASDAQ:CRON) dipped -3.81% to close Monday’s market session at $7.83, lower as compared to yesterday’s close. The stock price fluctuated between $7.815 and $8.16 throughout the trading session with the volume trading being 2424586 shares, which represented a significant variation when compared to the three months average volume of 5.07 million shares. The firm’s stock price fluctuated -6.34% within the last five trades and -16.79% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 40.57% in the last 6 months and -23.24% was subtracted to its value over the previous 3 months. CRON stock is trading at a margin of -6.69%, -17.11% and -0.56% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, CRON deals in the Healthcare domain. The stock is trading -50.54 percent below its 52-week high and 69.48 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -0.11. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Cronos Group Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
The stock’s market cap achieved a total value of $2.91 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 62.29 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.65, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 49.22 percent of Cronos Group Inc. shares are owned by insiders, and 14.53 percent are held by financial institutions. ADLER JASON MARC, the Director at Cronos Group Inc. (CRON) has sold 714,759 shares of firm on Mar 17 at a price of $10.07 against the total amount of $7.19 million. In another inside trade, GORENSTEIN MICHAEL RYAN, Executive Chairman of Cronos Group Inc. (NASDAQ:CRON) sold 130,000 shares of the firm on Mar 15 for a total worth of $1.4 million at a price of $10.73. An inside trade which took place on Mar 15, Director of Cronos Group Inc. ADLER JASON MARC sold 452,810 shares of firm against total price of $4.82 million at the cost of $10.65 per share.